Search

Search Constraints

You searched for: Author/Creator Tsourlakis, Maria Christina

Search Results

1. 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer. Issue 10 (20th August 2018)

2. 5q21 deletion is often heterogeneous in prostate cancer. Issue 8 (24th January 2019)

3. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer. Issue 3 (2nd November 2015)

4. Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer. Issue 1 (29th November 2019)

5. High concordance of findings obtained from transgluteal magnetic resonance imaging ‐ and transrectal ultrasonography‐guided biopsy as compared with prostatectomy specimens. (11th April 2017)

6. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers. Issue 6 (19th July 2013)

7. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder. (2nd May 2019)

8. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence. (28th October 2020)

9. Loss of CCAAT‐enhancer‐binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers. Issue 3 (14th November 2018)

10. NY‐ESO‐1 expression is tightly linked to TMPRSS2–ERG fusion in prostate cancer. Issue 10 (1st May 2014)